New language has been added to leading shingles vaccine Shingrix over concerns that the injection may be responsible for an increased risk of a rare neurological autoimmune disease known as GBS, or Guillain-Barré Syndrome.
GBS occurs when the patient’s immune system attacks their nerve cells. It is diagnosed just 3,000 to 6,000 times a year and has been linked as a side effect of other vaccines as well, including ...
continue reading...